
GB40142
CD161
Also known as 4-(6-methoxy-2-methyl-4-quinolin-4-yl-9H-pyrimido[4,5-b]indol-7-yl)-3,5-dimethyl-1,2-oxazole
CD161 is a potent, orally active and selective BET bromodomain inhibitor (Ki values of 8·2 nM and 1·4 nM for BRD4 BD1 and BD2, respectively)· CD161 inhibits cell growth in acute leukemia cell lines and breast cancer cell lines· Moreover, CD161 has an excellent oral pharmacokinetic profile and, orally administered, effectively inhibits tumor growth in mice
ChemicalCAS1627716-22-6MW435.48FormulaC26H21N5O2
- CAS number
- 1627716-22-6
- Molecular weight
- 435.48
- Formula
- C26H21N5O2
- InChIKey
- AEANZCXROGPSBY-UHFFFAOYSA-N
- Catalogue number
- GB40142
- Brand
- GLPBIO
Computed properties PubChem CID 90395752 · XLogP 5.2 · TPSA 89.7 Ų · H-bond donors 1
- XLogP
- 5.2
- TPSA
- 89.7 Ų
- H-bond donors
- 1
- H-bond acceptors
- 6
- Rotatable bonds
- 3
- Heavy atoms
- 33
SMILES CC1=C(C(=NO1)C)C2=C(C=C3C(=C2)NC4=NC(=NC(=C34)C5=CC=NC6=CC=CC=C56)C)OC
Computed descriptors from PubChem (CID 90395752), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il